The EASEE® System is an innovative transcranial brain stimulation method that involves subcutaneous electrodes placed outside the cranium.

Profit from progress

The EASEE® System is suitable for people suffering from focal seizures, where medication is either inadequate or no longer provides relief. The EASEE® System is currently undergoing clinical testing and is not yet available on the market. Are you interested in taking part in a clinical trial with the EASEE® System? If so, simply contact Precisis AG. Click here to find out which European epilepsy centre is right for you and where you can take a preliminary test to determine your suitability.


More information
 

Their lives inspire us…

  • Britta, 37 years, Hamburg

    “Medication helped me suppress my focal seizures for 15 years, but the attacks returned just one-and-a-half years after my son was born. I have been unable to work since 2015 and am currently a temporary pensioner. I suffer from impaired vision and speech disorders as a result of the medication, my perception is sometimes altered, I have put on weight and now have more spots than I had in puberty. My liver function tests aren’t all that good and I am also suffering slightly from osteoporosis. My experiences with mobile vagus nerve stimulation are not very happy ones and I am very scared of deep brain stimulation and the associated risks. Superficial brain stimulation would be a welcome alternative for me and one I can easily imagine testing.”

    Britta, 37 years, Hamburg
  • Julian, 22 years, Heidelberg

    “I had my first Grand Mal attack when I was 12. In the following years, I suffered two or three attacks a day. My mesial temporal lobe epilepsy was not diagnosed until 2011. None of the medications reduced the number of attacks; instead, I was bothered by side-effects such as speech disorders and hallucinations. I would have preferred a less risky alternative to brain surgery to treat my epilepsy. But this was not an option in 2015.”

    Julian, 22 years, Heidelberg
  • Dr. Olga Simova, Hamburg Epilepsy Centre, Ev. Krankenhaus Alsterdorf gGmbH

    “Neuromodulation through electrical stimulation may be a good alternative for those epilepsy patients who do not respond to a therapy and where there is no possibility of surgically removing the "diseased” part of the brain. It can help some patients to return to work, maintain their relationship and social contacts and much more. It’s worth a try in any case. This is why the further development of stimulation methods such as EASEE® are so important. We have to make the most of every opportunity we have to help a patient.”

    Dr. Olga Simova, Hamburg Epilepsy Centre, Ev. Krankenhaus Alsterdorf gGmbH

The importance of an individual approach

Dr. med Angela Liedler, CEO of Precisis AG explains how EASEE® works: